116 related articles for article (PubMed ID: 18562852)
1. Delayed dark adaptation caused by nilutamide.
Chan P; Odel JG
J Neuroophthalmol; 2008 Jun; 28(2):158-9. PubMed ID: 18562852
[No Abstract] [Full Text] [Related]
2. Lung caught in Nilutamide treatment.
Lourenço EP; Nzwalo H; Sampaio MR; Brito H
BMJ Case Rep; 2016 Sep; 2016():. PubMed ID: 27599808
[No Abstract] [Full Text] [Related]
3. [Dark adaptation in workers chronically exposed to carbon disulfide. II. Impairment of dark adaptation and degree of exposure].
Leśnik H; Poborc-Godlewska J
Klin Oczna; 1982 Nov; 84(11):365-8. PubMed ID: 7183821
[No Abstract] [Full Text] [Related]
4. [Pulmonary toxicity of nilutamide (Anandron). Cooperative evaluation of French Regional Pharmacovigilance Centers].
Jonville AP; Diot E; Dutertre JP; Autret E
Therapie; 1992; 47(5):393-7. PubMed ID: 1299978
[TBL] [Abstract][Full Text] [Related]
5. Isotretinoin and night vision.
Pushpoth S; Sandramouli S
Br J Ophthalmol; 2007 Aug; 91(8):1096; author reply 1096. PubMed ID: 17638833
[No Abstract] [Full Text] [Related]
6. Ocular toxicity of anandron.
Brisset JM; Bertagna C; Proulx L
Br J Ophthalmol; 1987 Aug; 71(8):639-40. PubMed ID: 3651380
[No Abstract] [Full Text] [Related]
7. [Fatal fulminant hepatitis induced by nilutamide (Anandron)].
Pescatore P; Hammel P; Durand F; Bertheau P; Bernuau J; Huc D; Gerbal JL; Degott C; Benhamou JP
Gastroenterol Clin Biol; 1993; 17(6-7):499-501. PubMed ID: 8243938
[TBL] [Abstract][Full Text] [Related]
8. Ocular toxicity of Anandron in patients treated for prostatic cancer.
Harnois C; Malenfant M; Dupont A; Labrie F
Br J Ophthalmol; 1986 Jun; 70(6):471-3. PubMed ID: 3718913
[TBL] [Abstract][Full Text] [Related]
9. Nilutamide-induced neutropenia.
Eaton VS; Blackmore TK
BJU Int; 2001 Nov; 88(7):801-2. PubMed ID: 11890258
[No Abstract] [Full Text] [Related]
10. [Fatal fulminating hepatitis caused by nilutamide. A new case].
Marty F; Godart D; Doermann F; Mérillon H
Gastroenterol Clin Biol; 1996; 20(8-9):710-1. PubMed ID: 8977826
[No Abstract] [Full Text] [Related]
11. Fulminant hepatic failure due to nilutamide hepatotoxicity.
Merwat SN; Kabbani W; Adler DG
Dig Dis Sci; 2009 Apr; 54(4):910-3. PubMed ID: 18688719
[No Abstract] [Full Text] [Related]
12. Watchful waiting beats androgen deprivation therapy in early prostate cancer.
Brower V
J Natl Cancer Inst; 2008 Nov; 100(21):1494-6. PubMed ID: 18957680
[No Abstract] [Full Text] [Related]
13. Antiandrogen withdrawal syndrome with nilutamide.
Gomella LG; Ismail M; Nathan FE
J Urol; 1997 Apr; 157(4):1366. PubMed ID: 9120950
[No Abstract] [Full Text] [Related]
14. Degarelix (firmagon) for prostate cancer.
Med Lett Drugs Ther; 2009 Oct; 51(1323):82-3. PubMed ID: 19838145
[No Abstract] [Full Text] [Related]
15. Abnormal retinal function associated with fenretinide, a synthetic retinoid.
Kaiser-Kupfer MI; Peck GL; Caruso RC; Jaffe MJ; DiGiovanna JJ; Gross EG
Arch Ophthalmol; 1986 Jan; 104(1):69-70. PubMed ID: 2935125
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of salvage radiotherapy plus 2-year androgen suppression for postradical prostatectomy patients with PSA relapse.
Choo R; Danjoux C; Gardner S; Morton G; Szumacher E; Loblaw DA; Cheung P; Pearse M
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):983-9. PubMed ID: 19409726
[TBL] [Abstract][Full Text] [Related]
17. Testosterone recovery after prolonged androgen suppression in patients with prostate cancer.
Yoon FH; Gardner SL; Danjoux C; Morton G; Cheung P; Choo R
J Urol; 2008 Oct; 180(4):1438-43; discussion 1443-4. PubMed ID: 18710743
[TBL] [Abstract][Full Text] [Related]
18. Comment: clinical experiences of visual disturbances with nilutamide.
Dijkman GA; Klotz LH; Diokno AC; Zippe CD
Ann Pharmacother; 1997 Dec; 31(12):1550-2. PubMed ID: 9416403
[No Abstract] [Full Text] [Related]
19. Interferon beta-associated retinopathy in patients treated for multiple sclerosis.
Folden DV; Lee MS; Ryan EH
Neurology; 2008 Mar; 70(13 Pt 2):1153-5. PubMed ID: 18362275
[No Abstract] [Full Text] [Related]
20. [Demonstration by adaptoelectroretinography of the action of a cyanidin on nocturnal vision].
Rouher F; Sole P; Offret G; Bernard JA
Arch Ophtalmol Rev Gen Ophtalmol; 1972; 32(8):531-40. PubMed ID: 4267194
[No Abstract] [Full Text] [Related]
[Next] [New Search]
